Crinetics Pharmaceuticals
CRNX
Insider trades and stock quote 2024-2026
All insider trades at Crinetics Pharmaceuticals
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/2/2026
|
Sell |
Vivaldi, Coelho Rogerio |
Director |
$40.0 |
$120,000 |
|
6/17/2026
|
Sell |
Okey, Stephanie |
Director |
$35.9 |
$246,143 |
|
4/8/2026
|
Sell |
Knight, Jeff E. |
Chief Dev. & Operating Officer |
$40.1 |
$3,415,036 |
|
3/16/2026
|
Sell |
Struthers, Richard Scott |
President & CEO |
$37.4 |
$821,513 |
|
3/16/2026
|
Sell |
Betz, Stephen F. |
Chief Scientific Officer |
$37.4 |
$396,611 |
|
3/16/2026
|
Sell |
Knight, Jeff E. |
Chief Operating Officer |
$37.4 |
$370,412 |
|
3/12/2026
|
Sell |
Vivaldi, Coelho Rogerio |
Director |
$36.4 |
$180,761 |
|
3/3/2026
|
Sell |
Schilke, Tobin |
Chief Financial Officer |
$39.7 |
$266,305 |
|
3/3/2026
|
Sell |
Okey, Stephanie |
Director |
$39.7 |
$119,010 |
|
1/5/2026
|
Sell |
Kalofonos, Isabel |
Chief Commercial Officer |
$55.0 |
$137,500 |
|
12/1/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$45.0 |
$225,100 |
|
11/3/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$43.0 |
$213,312 |
|
10/1/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$41.8 |
$209,050 |
|
9/26/2025
|
Sell |
Fust, Matthew K. |
Director |
$44.8 |
$716,000 |
|
9/26/2025
|
Sell |
Struthers, Richard Scott |
President & CEO |
$45.0 |
$180,000 |
|
9/2/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$32.1 |
$160,500 |
|
8/22/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$30.4 |
$912,900 |
|
8/20/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$29.2 |
$189,437 |
|
6/12/2025
|
Sell |
Betz, Stephen F. |
Chief Scientific Officer |
$32.2 |
$3,141,877 |
|
3/19/2025
|
Sell |
Struthers, Richard Scott |
President & CEO |
$34.5 |
$593,017 |
|
3/19/2025
|
Sell |
Betz, Stephen F. |
Chief Scientific Officer |
$34.5 |
$197,353 |
|
3/19/2025
|
Sell |
Knight, Jeff E. |
Chief Operating Officer |
$34.5 |
$244,964 |
|
3/19/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$34.5 |
$86,021 |
|
2/3/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$39.1 |
$195,350 |
|
1/3/2025
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$52.1 |
$781,350 |
|
12/2/2024
|
Sell |
Struthers, Richard Scott |
President & CEO |
$57.6 |
$575,700 |
|
11/22/2024
|
Sell |
Knight, Jeff E. |
Chief Operating Officer |
$56.5 |
$28,317 |
|
10/3/2024
|
Sell |
Pizzuti, Dana |
Chief Med and Dev Officer |
$54.6 |
$785,306 |
|
9/26/2024
|
Sell |
Wilson, Marc |
CFO |
$51.1 |
$1,277,750 |
|
9/10/2024
|
Sell |
Betz, Stephen F. |
Chief Scientific Officer |
$51.5 |
$53,303 |
|
8/26/2024
|
Sell |
Betz, Stephen F. |
Chief Scientific Officer |
$53.2 |
$159,570 |
|
8/12/2024
|
Sell |
Betz, Stephen F. |
Chief Scientific Officer |
$47.7 |
$143,040 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now